QBTS vs. HQY, BILI, QXO, ETSY, LYFT, GLOB, AMTM, MARA, WSC, and RELY
Should you be buying D-Wave Quantum stock or one of its competitors? The main competitors of D-Wave Quantum include HealthEquity (HQY), Bilibili (BILI), QXO (QXO), Etsy (ETSY), Lyft (LYFT), Globant (GLOB), Amentum (AMTM), MARA (MARA), WillScot Mobile Mini (WSC), and Remitly Global (RELY). These companies are all part of the "business services" industry.
D-Wave Quantum vs.
D-Wave Quantum (NYSE:QBTS) and HealthEquity (NASDAQ:HQY) are both mid-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, community ranking, valuation, dividends and media sentiment.
42.5% of D-Wave Quantum shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 7.2% of D-Wave Quantum shares are owned by insiders. Comparatively, 2.2% of HealthEquity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
HealthEquity has a net margin of 8.41% compared to D-Wave Quantum's net margin of -783.28%. HealthEquity's return on equity of 9.70% beat D-Wave Quantum's return on equity.
D-Wave Quantum presently has a consensus price target of $8.42, indicating a potential upside of 17.88%. HealthEquity has a consensus price target of $111.75, indicating a potential upside of 29.82%. Given HealthEquity's higher possible upside, analysts clearly believe HealthEquity is more favorable than D-Wave Quantum.
D-Wave Quantum has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500.
HealthEquity received 508 more outperform votes than D-Wave Quantum when rated by MarketBeat users. However, 88.89% of users gave D-Wave Quantum an outperform vote while only 70.22% of users gave HealthEquity an outperform vote.
HealthEquity has higher revenue and earnings than D-Wave Quantum. D-Wave Quantum is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.
In the previous week, HealthEquity had 11 more articles in the media than D-Wave Quantum. MarketBeat recorded 28 mentions for HealthEquity and 17 mentions for D-Wave Quantum. D-Wave Quantum's average media sentiment score of 0.76 beat HealthEquity's score of 0.39 indicating that D-Wave Quantum is being referred to more favorably in the media.
Summary
HealthEquity beats D-Wave Quantum on 13 of the 18 factors compared between the two stocks.
Get D-Wave Quantum News Delivered to You Automatically
Sign up to receive the latest news and ratings for QBTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
D-Wave Quantum Competitors List
Related Companies and Tools
This page (NYSE:QBTS) was last updated on 4/24/2025 by MarketBeat.com Staff
Buy QBTS Stock Free QBTS Stock Alerts